Petco CFO Departs, New Directors Appointed
Ticker: WOOF · Form: 8-K · Filed: Apr 9, 2024 · CIK: 1826470
| Field | Detail |
|---|---|
| Company | Petco Health & Wellness Company, Inc. (WOOF) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-departure, board-changes, management-change
TL;DR
Petco CFO out, interim CFO in, 3 new board members named.
AI Summary
Petco Health & Wellness Company, Inc. announced on April 4, 2024, the departure of Chief Financial Officer, Michael Nuzzo. The company has appointed Brian Laederach as interim CFO. Additionally, the company elected three new directors to its Board: Amy Freeman, Jonathan Kindred, and Christopher Redlich.
Why It Matters
Changes in key executive positions and board composition can signal shifts in company strategy or financial direction, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Executive departures and board changes can introduce uncertainty regarding leadership stability and strategic direction.
Key Players & Entities
- Petco Health & Wellness Company, Inc. (company) — Registrant
- Michael Nuzzo (person) — Departing Chief Financial Officer
- Brian Laederach (person) — Interim Chief Financial Officer
- Amy Freeman (person) — Elected Director
- Jonathan Kindred (person) — Elected Director
- Christopher Redlich (person) — Elected Director
- April 4, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the interim Chief Financial Officer?
Brian Laederach has been appointed as the interim Chief Financial Officer.
When was the earliest event reported in this filing?
The earliest event reported was on April 4, 2024.
Who is the departing Chief Financial Officer?
Michael Nuzzo is the departing Chief Financial Officer.
How many new directors were elected to the Board?
Three new directors were elected to the Board: Amy Freeman, Jonathan Kindred, and Christopher Redlich.
What is the company's principal executive office address?
The principal executive office address is 10850 Via Frontera, San Diego, California 92127.
Filing Stats: 463 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2024-04-09 17:01:07
Key Financial Figures
- $0.001 — stered Class A common stock, par value $0.001 per share WOOF The Nasdaq Stock Mar
Filing Documents
- d817913d8k.htm (8-K) — 21KB
- 0001193125-24-090944.txt ( ) — 136KB
- woof-20240404.xsd (EX-101.SCH) — 3KB
- woof-20240404_lab.xml (EX-101.LAB) — 17KB
- woof-20240404_pre.xml (EX-101.PRE) — 11KB
- d817913d8k_htm.xml (XML) — 3KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2024 Petco Health and Wellness Company, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39878 81-1005932 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 10850 Via Frontera San Diego , California 92127 (Address of Principal Executive Offices) (858) 453-7845 (Registrant's Telephone Number, Including Area Code) (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Class A common stock, par value $0.001 per share WOOF The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 4, 2024, the Board of Directors (the "Board") of Petco Health and Wellness Company, Inc. (the "Company") approved the termination of employment of Darren MacDonald, the Company's Chief Customer Officer, effective as of April 12, 2024, which constitutes a termination of Mr. MacDonald's employment without cause under the Company's Executive Severance Plan. Subject to his execution of a release of claims, Mr. MacDonald will be eligible for the separation benefits set forth under the Company's Executive Severance Plan and his outstanding award agreements. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Petco Health and Wellness Company, Inc. Date: April 9, 2024 By: /s/ Giovanni Insana Name: Giovanni Insana Title: Chief Legal Officer and Secretary